You are here
- Home
- Total number of clinical trials
A Randomized, Double-Blind, Placebo-Controlled 12-Week Extension Study to Assess the Safety and Tolerability of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
- Disease
- pain
- Drug Name
- NKTR 118
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- III
- Start Date
- Jan 18, 1971
- Study Name
- D3820C00007
- Study Id
- D3820C00007
- ClinicalTrials.gov ID
- NCT01395524
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
